title: Salvage surgery for advanced non-small cell lung cancer after response to gefitinib.
authors.affiliation: Division of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. thishida@nifty.com
authors.forename: Tomoyuki
authors.initials: T
authors.lastname: Hishida
authors.forename: Kanji
authors.initials: K
authors.lastname: Nagai
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Mitsudomi
authors.forename: Kohei
authors.initials: K
authors.lastname: Yokoi
authors.forename: Haruhiko
authors.initials: H
authors.lastname: Kondo
authors.forename: Hirohisa
authors.initials: H
authors.lastname: Horinouchi
authors.forename: Hirohiko
authors.initials: H
authors.lastname: Akiyama
authors.forename: Takeshi
authors.initials: T
authors.lastname: Nagayasu
authors.forename: Masahiro
authors.initials: M
authors.lastname: Tsuboi
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000556:secondary / Q000601:surgery*; D018572:Disease-Free Survival; D066246:ErbB Receptors / Q000235:genetics; D005260:Female; D000077156:Gefitinib; D006801:Humans; D007564:Japan; D053208:Kaplan-Meier Estimate; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009364:Neoplasm Recurrence, Local / Q000601:surgery; D009367:Neoplasm Staging; D018365:Neoplasm, Residual / Q000601:surgery; D011013:Pneumonectomy / Q000009:adverse effects / Q000401:mortality; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D016879:Salvage Therapy; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; C512478:EGFR protein, human; D066246:ErbB Receptors; D000077156:Gefitinib